3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
11
Neoplasms
7
Leukemia, Myeloid, Acute
7
Lung Neoplasms
5
Ovarian Neoplasms
4
Fatigue
4
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Lymphoma
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Multiple Myeloma
2
Melanoma
2
Leukemia
2
Hematologic Neoplasms
2
Glioma
2
Genital Neoplasms, Female
2
Esophageal Neoplasms
2
Depression
2
Weight Loss
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Interventions
Cyclophosphamide
216
Methotrexate
140
Cytarabine
131
Vincristine
110
fludarabine phosphate
103
Peripheral Blood Stem Cell Transplantation
98
Filgrastim
92
Etoposide
92
Dexamethasone
89
Mycophenolic Acid
71
Doxorubicin
70
Whole-Body Irradiation
67
Mercaptopurine
66
Busulfan
65
Tacrolimus
64
Radiotherapy
63
Cyclosporine
62
Prednisone
55
Daunorubicin
53
pegaspargase
51
Asparaginase
51
Rituximab
48
fludarabine
47
Granulocyte Colony-Stimulating Factor
46
Melphalan
45
Antilymphocyte Serum
43
Clofarabine
42
Calcium Dobesilate
38
Methylprednisolone
36
Leucovorin
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Palliative Care
×
Clear all
NCT00902213
2015-11-17
PAQOL
St. Jude Children's Research Hospital
Phase NA
Completed
122 enrolled